Search research articles
Contact Us
Filters
Showing results (51-60 of 67) with videos related to
Page
of 7
Sort By:
Expert Opinion on Investigational Drugs
|
August 21, 2024
The first-in-human study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of the factor XI monoclonal antibody SHR-2004 in healthy subjects
Tingting Ma, Zuyi Weng, Bei Cao, et al.
Heliyon
|
December 11, 2023
Rapid Raman spectroscopic identification of three homoisoflavanones in polygonatum odoratum based on twice chromatography derivatization
Tao Xu, Qian Li, Feng Xu, et al.
Clinical Drug Investigation
|
June 16, 2023
The Safety, Pharmacokinetics, and Pharmacodynamics of SHR2285, an Oral Small Molecule Factor XIa Inhibitor, in Healthy Chinese Volunteers
Junyu Xu, Nan Zhao, Jie Huang, et al.
Nature Communications
|
January 12, 2026
Enhancing carbon sinks in China using a spatially-optimized forestation strategy
Yanli Dong, Zhen Yu, Thomas Pugh, et al.
Cell Reports
|
November 3, 2021
Closed-state inactivation and pore-blocker modulation mechanisms of human Ca<sub>V</sub>2.2
Yanli Dong, Yiwei Gao, Shuai Xu, et al.
Nature Communications
|
July 16, 2025
Molecular mechanism of drug inhibition of URAT1
Zhuoya Yu, Tuo Hu, Jiawei Su, et al.
Nature Communications
|
March 12, 2022
Structural basis for modulation of human Na<sub>V</sub>1.3 by clinical drug and selective antagonist
Xiaojing Li, Feng Xu, Hao Xu, et al.
Frontiers in Pharmacology
|
November 7, 2022
SHR2285, the first selectively oral FXIa inhibitor in China: Safety, tolerability, pharmacokinetics and pharmacodynamics combined with aspirin, clopidogrel or ticagrelor
Tingting Ma, Yanli Dong, Lei Huang, et al.
Nature Communications
|
May 13, 2024
Author Correction: Maximizing carbon sequestration potential in Chinese forests through optimal management
Zhen Yu, Shirong Liu, Haikui Li, et al.
Nature
|
September 23, 2021
Kainate receptor modulation by NETO2
Lingli He, Jiahui Sun, Yiwei Gao, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 67) with videos related to
Sort By:
Page
of 7
Expert Opinion on Investigational Drugs
|
August 21, 2024
The first-in-human study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of the factor XI monoclonal antibody SHR-2004 in healthy subjects
Tingting Ma, Zuyi Weng, Bei Cao, et al.
Heliyon
|
December 11, 2023
Rapid Raman spectroscopic identification of three homoisoflavanones in polygonatum odoratum based on twice chromatography derivatization
Tao Xu, Qian Li, Feng Xu, et al.
Clinical Drug Investigation
|
June 16, 2023
The Safety, Pharmacokinetics, and Pharmacodynamics of SHR2285, an Oral Small Molecule Factor XIa Inhibitor, in Healthy Chinese Volunteers
Junyu Xu, Nan Zhao, Jie Huang, et al.
Nature Communications
|
January 12, 2026
Enhancing carbon sinks in China using a spatially-optimized forestation strategy
Yanli Dong, Zhen Yu, Thomas Pugh, et al.
Cell Reports
|
November 3, 2021
Closed-state inactivation and pore-blocker modulation mechanisms of human Ca<sub>V</sub>2.2
Yanli Dong, Yiwei Gao, Shuai Xu, et al.
Nature Communications
|
July 16, 2025
Molecular mechanism of drug inhibition of URAT1
Zhuoya Yu, Tuo Hu, Jiawei Su, et al.
Nature Communications
|
March 12, 2022
Structural basis for modulation of human Na<sub>V</sub>1.3 by clinical drug and selective antagonist
Xiaojing Li, Feng Xu, Hao Xu, et al.
Frontiers in Pharmacology
|
November 7, 2022
SHR2285, the first selectively oral FXIa inhibitor in China: Safety, tolerability, pharmacokinetics and pharmacodynamics combined with aspirin, clopidogrel or ticagrelor
Tingting Ma, Yanli Dong, Lei Huang, et al.
Nature Communications
|
May 13, 2024
Author Correction: Maximizing carbon sequestration potential in Chinese forests through optimal management
Zhen Yu, Shirong Liu, Haikui Li, et al.
Nature
|
September 23, 2021
Kainate receptor modulation by NETO2
Lingli He, Jiahui Sun, Yiwei Gao, et al.
Page
of 7